CUSIP: 61240F108
Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,829,169
-
Share change
-
-6,737,661
-
Total reported value
-
$19,176,146
-
Price per share
-
$10.50
-
Number of holders
-
16
-
Value change
-
-$69,314,764
-
Number of buys
-
5
-
Number of sells
-
28
Quarterly Holders Quick Answers
What is CUSIP 61240F108?
CUSIP 61240F108 identifies MTRY - MONTEREY BIO ACQUISITION COR - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2023
-
Previous quarter:
Q3 2022
Recent filing periods for CUSIP 61240F108:
Institutional Holders of MONTEREY BIO ACQUISITION COR - COM (MTRY) as of Q4 2022
As of 31 Dec 2022,
MONTEREY BIO ACQUISITION COR - COM (MTRY) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,829,169 shares.
The largest 10 holders included
MMCAP International Inc. SPC, Periscope Capital Inc., Polar Asset Management Partners Inc., Owl Creek Asset Management, L.P., FIR TREE CAPITAL MANAGEMENT LP, RIVERNORTH CAPITAL MANAGEMENT, LLC, AQR Arbitrage LLC, SkyView Investment Advisors, LLC, Walleye Capital LLC, and Walleye Trading LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.